Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer.

Suppr

超能文献

作者信息

Gordan G S, Halden A, Horn Y, Fuery J J, Parsons R J, Walter R M

出版信息

Oncology. 1973;28(2):138-46. doi: 10.1159/000224811.

DOI:10.1159/000224811

PMID:4583006

Abstract

摘要

相似文献

Calusterone (7beta,17alpha-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer.

Oncology. 1973;28(2):138-46. doi: 10.1159/000224811.

Antitumor efficacy of 7 beta, 17 alpha-dimethyltestosterone (Calusterone) in advanced female breast cancer.

Calif Med. 1970 Sep;113(3):1-10.

Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.

Cancer Chemother Rep. 1974 Nov-Dec;58(6):939-41.

Effect of 7beta, 17alpha-dimethyltestosterone (calusterone) on cortisol metabolism in women with advanced breast cancer.

J Clin Endocrinol Metab. 1976 Jul;43(1):38-45. doi: 10.1210/jcem-43-1-38.

Leucopoietic effect of calusterone (7 beta, 17 alpha-dimethyltestosterone) in women with advanced breast cancer.

Scand J Haematol. 1973;10(3):177-80. doi: 10.1111/j.1600-0609.1973.tb00056.x.

7beta,17alpha-Dimethyltestosterone (calusterone)-induced changes in the metabolism, production rate, and excretion of estrogens in women with breast cancer: a possible mechanism of action.

J Clin Endocrinol Metab. 1976 Feb;42(2):365-9. doi: 10.1210/jcem-42-2-365.

Calusterone.

Ann Intern Med. 1978 Dec;89(6):945-8. doi: 10.7326/0003-4819-89-6-945.

[Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases].

Sem Hop. 1974;50(50-51):3099-105.

Male breast cancer: two cases with objective regressions from calusterone (7 alpha, 17 beta-dimethyltestosterone) after failure of orchiectomy.

Oncology. 1976;33(4):188-91. doi: 10.1159/000225140.

Calusterone treatment of breast cancer.

JAMA. 1972 Apr 24;220(4):588.

引用本文的文献

Revisiting Androgen Receptor Signaling in Breast Cancer.

Oncologist. 2023 May 8;28(5):383-391. doi: 10.1093/oncolo/oyad049.

Modulating the Activity of Androgen Receptor for Treating Breast Cancer.

Int J Mol Sci. 2022 Dec 5;23(23):15342. doi: 10.3390/ijms232315342.

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.

Oncologist. 2019 Jun;24(6):743-e205. doi: 10.1634/theoncologist.2018-0243. Epub 2018 Dec 27.

Targeting the androgen receptor in breast cancer.

Curr Oncol Rep. 2015 Feb;17(2):4. doi: 10.1007/s11912-014-0427-8.

Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide.

J Cancer Res Clin Oncol. 1995;121(3):150-4. doi: 10.1007/BF01198096.

Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells.

J Cancer Res Clin Oncol. 1995;121(12):710-4. doi: 10.1007/BF01213316.

Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Breast Cancer Res Treat. 1988 Oct;12(2):213-25. doi: 10.1007/BF01805942.

Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Breast Cancer Res Treat. 1989 Dec;14(3):299-306. doi: 10.1007/BF01806301.

Anti-tumour efficacy of calusterone against DMBA-induced rat mammary adenocarcinoma in vivo and in organ culture.

Br J Cancer. 1976 Mar;33(3):336-41. doi: 10.1038/bjc.1976.48.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验